Search All UT System Experts

Differential outcomes in codon 12/13 and codon 61 NRAS-mutated cancers in the Phase II NCI-MATCH trial of binimetinib in patients with NRAS-mutated tumors

James M. Cleary, Victoria Wang, Rebecca S. Heist, E. Scott Kopetz, Edith P. Mitchell, James A. Zwiebel, Kevin S. Kapner, Helen X. Chen, Shuli Li, Robert J. Gray, Lisa M. McShane, Larry V. Rubinstein, David R. Patton, Funda Meric-Bernstam, Melissa S. Dillmon, P. Mickey Williams, Stanley R. Hamilton, Barbara A. Conley, Andrew J. Aguirre, Peter J. O'DwyerLyndsay N. Harris, Carlos L. Arteaga, Alice P. Chen, Keith T. Flaherty

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Differential outcomes in codon 12/13 and codon 61 NRAS-mutated cancers in the Phase II NCI-MATCH trial of binimetinib in patients with NRAS-mutated tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences